Atle Fund Management AB

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1381843 STOCKHOLM, V7

Position in MIRM

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$18,085,047

+$11,000,829 QoQ

Shares Held

195,768

+118.3% QoQ

Ownership

0.321%

of shares outstanding

% of Portfolio

3.90%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Atle Fund Management AB holds $202,705,517 across 20 Biotechnology names. MIRM ranks #3 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	617,245	$60,027,076
2	BCAX	Bicara Therapeutics Inc.	1,169,634	$23,264,020
3	MIRM	Mirum Pharmaceuticals, Inc. This page	195,768	$18,085,047
4	CELC	Celcuity Inc.	141,296	$16,127,525
5	INSM	INSMED Inc	97,438	$15,933,061
6	ONC	BeOne Medicines Ltd.	41,717	$12,388,697
7	VRTX	Vertex Pharmaceuticals Inc / Ma	22,984	$10,263,275
8	KRYS	Krystal Biotech, Inc.	37,579	$9,707,407

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,085,047	195,768	+118.3%	Shares	Sole	2026-05-11
2025-12-31	$7,084,218	89,685	-4.2%	Shares	Sole	2026-02-06
2025-09-30	$6,862,182	93,605	-12.4%	Shares	Sole	2025-11-04
2025-06-30	$5,440,751	106,912	+38.4%	Shares	Sole	2025-07-14
2025-03-31	$3,480,698	77,263	-33.8%	Shares	Sole	2025-05-05
2024-12-31	$4,825,214	116,692	-15.6%	Shares	Sole	2025-02-04
2024-09-30	$5,394,519	138,321	+83.9%	Shares	Sole	2024-11-12
2024-06-30	$2,571,088	75,200	-38.9%	Shares	Sole	2024-08-14
2024-03-31	$3,089,760	123,000	—	Shares	Sole	2024-04-25
No filing history on record for this holder in this stock.